Wordt geladen...
Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...
Bewaard in:
| Gepubliceerd in: | Ital J Pediatr |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4681171/ https://ncbi.nlm.nih.gov/pubmed/26670908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-015-0203-x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|